Cdc25A and Dub3 in a High-stakes Balancing Act

Overview

Journal Nat Cell Biol

Specialty Cell Biology

Date 2010 Mar 16

PMID 20228807

Citations 6

Authors

Sebastian D Hayes

J Wade Harper

Affiliations

Soon will be listed here.

Abstract

The deubiquitylating enzyme Dub3 is found to have oncogenic potential by stabilizing the Cdc25A protein phosphatase, a crucial regulator of cell-cycle progression.

Citing Articles

Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1.

Wen Y, Yang X, Li S, Huang L, Chen J, Tan L MedComm (2020). 2025; 6(3):e70103.

PMID: 39968498 PMC: 11832431. DOI: 10.1002/mco2.70103.

DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma.

Jia X, Li L, Wang F, Xue Y, Wu T, Jia Q Cell Death Discov. 2022; 8(1):166.

PMID: 35383144 PMC: 8983766. DOI: 10.1038/s41420-022-00988-5.

A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival.

Lara-Chica M, Correa-Saez A, Jimenez-Izquierdo R, Garrido-Rodriguez M, Ponce F, Moreno R Cell Death Differ. 2021; 29(1):105-117.

PMID: 34363019 PMC: 8738746. DOI: 10.1038/s41418-021-00845-5.

Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances.

Chen R, Yang F, Zhang M, Sun Z, Zhang N Front Oncol. 2021; 11:671548.

PMID: 34026649 PMC: 8138054. DOI: 10.3389/fonc.2021.671548.

The regulation of snail: on the ubiquitin edge.

Yu Q, Zhou B, Wu Y Cancer Cell Microenviron. 2017; 4(2).

PMID: 29147673 PMC: 5685547.

References

Busino L, Chiesa M, Draetta G, Donzelli M . Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene. 2004; 23(11):2050-6. DOI: 10.1038/sj.onc.1207394. View

Sowa M, Bennett E, Gygi S, Harper J . Defining the human deubiquitinating enzyme interaction landscape. Cell. 2009; 138(2):389-403. PMC: 2716422. DOI: 10.1016/j.cell.2009.04.042. View

Loffler H, Syljuasen R, Bartkova J, Worm J, Lukas J, Bartek J . Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines. Oncogene. 2003; 22(50):8063-71. DOI: 10.1038/sj.onc.1206976. View

Pereg Y, Liu B, ORourke K, Sagolla M, Dey A, Komuves L . Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nat Cell Biol. 2010; 12(4):400-6. DOI: 10.1038/ncb2041. View

Stevenson L, Sparks A, Allende-Vega N, Xirodimas D, Lane D, Saville M . The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 2007; 26(4):976-86. PMC: 1852834. DOI: 10.1038/sj.emboj.7601567. View

Burrows J, McGrattan M, Johnston J . The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. Genomics. 2005; 85(4):524-9. DOI: 10.1016/j.ygeno.2004.11.013. View

Welcker M, Clurman B . FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 2007; 8(2):83-93. DOI: 10.1038/nrc2290. View

Shan J, Zhao W, Gu W . Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell. 2009; 36(3):469-76. PMC: 2856324. DOI: 10.1016/j.molcel.2009.10.018. View

Komander D, Clague M, Urbe S . Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009; 10(8):550-63. DOI: 10.1038/nrm2731. View

10.

Malumbres M, Barbacid M . Mammalian cyclin-dependent kinases. Trends Biochem Sci. 2005; 30(11):630-41. DOI: 10.1016/j.tibs.2005.09.005. View

11.

Lee G, White L, Hurov K, Stappenbeck T, Piwnica-Worms H . Response of small intestinal epithelial cells to acute disruption of cell division through CDC25 deletion. Proc Natl Acad Sci U S A. 2009; 106(12):4701-6. PMC: 2660721. DOI: 10.1073/pnas.0900751106. View

12.

Luo J, Solimini N, Elledge S . Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009; 136(5):823-37. PMC: 2894612. DOI: 10.1016/j.cell.2009.02.024. View

13.

Nicolini A, Carpi A, Rossi G . Cytokines in breast cancer. Cytokine Growth Factor Rev. 2006; 17(5):325-37. DOI: 10.1016/j.cytogfr.2006.07.002. View

14.

Boutros R, Lobjois V, Ducommun B . CDC25 phosphatases in cancer cells: key players? Good targets?. Nat Rev Cancer. 2007; 7(7):495-507. DOI: 10.1038/nrc2169. View

15.

Melixetian M, Klein D, Sorensen C, Helin K . NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint. Nat Cell Biol. 2009; 11(10):1247-53. DOI: 10.1038/ncb1969. View